Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study

202216 citationsJournal Articlegold Open Access

Authors

F. Borges

Filipa Alves da Costa · University of Lisbon

Cláudia Furtado · Ordem dos Médicos

Arlindo R. Ferreira · Champalimaud Foundation

Diogo Martins-Branco

Abstract

Palbociclib plus fulvestrant seems an effective treatment for ABC in real-world context. Compared to registrations studies, rwPFS and rwOS were shorter in real-life setting.

Topics & Keywords

Advanced Breast Cancer Therapies Cancer-related Molecular Pathways Chronic Lymphocytic Leukemia Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Breast

Volume 62, pp. 135-143

DOI: 10.1016/j.breast.2022.02.005

Field-Weighted Citation Impact: 2.13